Moreover, myeloid cells in the TME can release interleukin-4-induced-1 (IL4i1), a secreted amino acid oxidase that mediates the production of indole-3-pyruvate (I3P) from tryptophan, to thus block ferroptosis and support tumour growth [188]. Here, IL4I1 is linked to neoplasm.